1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow SPI-2012: new trials by email Literature Review of SPI-2012 trials Research Report on SPI-2012
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of SPI-2012 (Eflapegrastim) in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide (TC) Chemotherapy SPI-2012 - Breast Cancer, Pharmacokinetics | Phase 1 | Completed | Spectrum Pharmaceuticals, Inc | 26 | 2017-05-11 | 2020-11-13 |
Breast Neoplasms (1)
Spectrum Pharmaceuticals, Inc (1)
United States (1)